News | October 06, 2014

ProNova and medPhoton to Offer Next Generation Beam Delivery, Advanced Imaging for Proton Therapy

ProNova medPhoton Next Generation Beam Delivery Advanced Imaging Proton Therapy

October 6, 2014 — ProNova Solutions and medPhoton announced that they have agreed to form an exclusive partnership that will merge leading edge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market.

ProNova will integrate the medPhoton ImagingRing system into the SC360 proton therapy solution. The resulting system will include Fast Scanning IMPT technology with integrated 3-D imaging. This unique solution merges leading edge pencil beam delivery, innovative dual-energy 3-D imaging capability and precision positioning to aid physicians and therapists in minimizing collateral damage to healthy tissue and maximizing dose to the tumor. The ProNova compact superconducting gantry design allows for 360 degrees of patient treatment angle and improved workflow, resulting in faster treatment times and higher productivity.

medPhoton´s newly developed ImagingRing system is a slim, couch based, in-room CBCT device, capable of large field of view, low dose, single source dual energy 3-D volumetric and 2-D planar image acquisitions. It supports smooth workflows and highest precision in inter- and intrafractional image guided radiotherapy.

“medPhoton is glad that our hard research and development work over the last years will now have a real impact on the field. After having installed our first unit at the carbon beam facility MedAustron, we will now integrate our slim imaging ring system with ProNova’s cutting edgesmall footprint proton therapy equipment. In combination of both systems, precise beam adaptation and tracking of moving targets will be possible in the near future. A series of joint installations, research and clinical has been ordered,” says Heinz Deutschmann, chief executive officer and founder of medPhoton.

“ProNova is proud to partner with an innovative company like medPhoton,” said Joe Matteo, division president of ProNova Solutions, R&D and manufacturing. “Together we feel that this unique solution will enable clinicians to develop advanced proton therapy protocols for Adaptive Therapy.”

For more information: www.medphoton.at, pronovasolutions.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init